Atlas Capital Advisors Inc. Takes $1.65 Million Position in Tenet Healthcare Corporation $THC

Atlas Capital Advisors Inc. purchased a new stake in Tenet Healthcare Corporation (NYSE:THC) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 8,325 shares of the company’s stock, valued at approximately $1,654,000.

Several other large investors have also made changes to their positions in the company. Wedmont Private Capital grew its stake in shares of Tenet Healthcare by 2.5% in the 4th quarter. Wedmont Private Capital now owns 2,088 shares of the company’s stock valued at $422,000 after buying an additional 50 shares in the last quarter. Baron Wealth Management LLC grew its stake in shares of Tenet Healthcare by 4.8% in the 4th quarter. Baron Wealth Management LLC now owns 1,142 shares of the company’s stock valued at $227,000 after buying an additional 52 shares in the last quarter. Sagespring Wealth Partners LLC grew its stake in shares of Tenet Healthcare by 3.6% in the 4th quarter. Sagespring Wealth Partners LLC now owns 1,573 shares of the company’s stock valued at $313,000 after buying an additional 55 shares in the last quarter. Quadrant Capital Group LLC grew its stake in shares of Tenet Healthcare by 0.7% in the 4th quarter. Quadrant Capital Group LLC now owns 8,134 shares of the company’s stock valued at $1,616,000 after buying an additional 58 shares in the last quarter. Finally, Syon Capital LLC grew its stake in shares of Tenet Healthcare by 5.3% in the 4th quarter. Syon Capital LLC now owns 1,254 shares of the company’s stock valued at $249,000 after buying an additional 63 shares in the last quarter. Institutional investors own 95.44% of the company’s stock.

Insider Activity at Tenet Healthcare

In other news, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the sale, the director directly owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. This represents a 25.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Nadja West sold 3,000 shares of the company’s stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the transaction, the director owned 24,805 shares of the company’s stock, valued at $4,399,166.75. The trade was a 10.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.97% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Stephens lowered their price target on Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating for the company in a research note on Monday, May 4th. Morgan Stanley set a $254.00 price target on Tenet Healthcare in a report on Friday, May 1st. Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a research report on Wednesday, March 4th. Wells Fargo & Company cut their price objective on Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Finally, Weiss Ratings cut Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 2nd. Eighteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, Tenet Healthcare has an average rating of “Moderate Buy” and an average target price of $244.16.

Tenet Healthcare Stock Up 0.9%

THC opened at $174.67 on Friday. Tenet Healthcare Corporation has a 1-year low of $146.60 and a 1-year high of $247.21. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. The stock has a market capitalization of $15.05 billion, a price-to-earnings ratio of 9.08, a P/E/G ratio of 1.44 and a beta of 1.28. The business has a 50 day moving average of $183.94 and a 200-day moving average of $199.94.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, beating the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The company had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. During the same period in the prior year, the business earned $4.36 earnings per share. Tenet Healthcare’s revenue for the quarter was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, sell-side analysts anticipate that Tenet Healthcare Corporation will post 17.61 earnings per share for the current year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.